On the 23rd, the Ministry of Food and Drug Safety approved clinical trials for the new coronavirus infection (Corona 19)

On the 23rd, the Ministry of Food and Drug 선릉안마 Safety approved clinical trials for the new coronavirus infection (Corona 19) vaccine "NBP2001" under development by SK Bioscience and the Corona 19 treatment "DW2008S" under development by Donghwa Pharmaceutical. As a result, a total of 30 clinical trials have been approved in Korea regarding Corona19, of which 22 (19 treatments and 3 vaccines) are undergoing clinical trials (Table). "NBP2001" is a "re-combination vaccine" that manufactures the 역삼안마 "surface antigen protein" of the Corona 19 virus using gene recombination technology, and the latest approved clinical trial is a first-phase clinical test to assess safety and immune origin in healthy adults. "NBP2001" has the principle that the vaccine's surface antigen protein stimulates immune cells to induce immune responses, 신림노래방 and that antibodies remove the corona 19 virus in the event of a corona 19 virus invasion.